BioMarin Pharmaceutical

Biotechnology

BioMarin develops therapies for rare genetic diseases, including enzyme replacement therapies and gene therapies. The company's focus on small patient populations with high unmet need exemplifies the orphan drug model. BioMarin's diverse portfolio includes treatments for metabolic disorders, hemophilia, and skeletal dysplasias.

The Biology of Business

Sign up to be notified when the book is available to order.

Notify Me